The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...
One such innovation is Retratutide, a novel drug developed by Eli Lilly that targets both obesity and type 2 diabetes. As ...
A recent study from Western University has found that a natural compound found in sweet oranges and tangerines, called ...
A new poll from the Episcopal Health Foundation found that 63 percent of Texans have skipped care because of high healthcare ...
In the Trump administration’s quest to “Make America Healthy Again,” there may be no bigger target than ultraprocessed foods.
23h
MedPage Today on MSNHigh Price of GLP-1 Agents Tip Cost-Benefit Scale UnfavorablyTirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
New research has found that large weight changes—both weight gain and weight loss—can significantly increase the risk of ...
Using the well-established NICE-accredited Gro Health digital platform, GroW will provide women with adaptive care plans that ...
As a neurologist at the forefront of research into Alzheimer's disease, I have worked with people who have managed to stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results